{
  "metadata": {
    "generated_at": "1762911750.5767143",
    "total_queries": 10,
    "successful_queries": 10,
    "failed_queries": 0
  },
  "statistics": {
    "total_nodes": 105,
    "total_relationships": 574,
    "node_types": {
      "ProcedureStep": 22,
      "ReferenceDocument": 14,
      "Reagent": 10,
      "IntendedUse": 8,
      "Instrument": 6,
      "SOP": 6,
      "Limitation": 6,
      "FDADocument": 5,
      "Device": 4,
      "Result": 3,
      "Assay": 3,
      "SpecimenType": 3,
      "Modification": 3,
      "Indication": 3,
      "RegulatorySection": 2,
      "Analyte": 1,
      "Classification": 1,
      "ProductCode": 1,
      "Manufacturer": 1,
      "PerformanceCharacteristic": 1,
      "Standard": 1,
      "Guideline": 1
    },
    "relationship_types": {
      "SOP_HAS_PROCEDURE_STEP": 124,
      "SOP_REFERENCES_DOCUMENT": 53,
      "STEP_USES_REAGENT": 49,
      "STEP_PRECEDES": 41,
      "SOP_HAS_LIMITATION": 31,
      "DEVICE_HAS_MODIFICATION": 30,
      "STEP_REQUIRES_EQUIPMENT": 28,
      "DOCUMENT_DESCRIBES_DEVICE": 27,
      "ASSAY_USES_REAGENT": 21,
      "SOP_HAS_INTENDED_USE": 17,
      "INTENDED_USE_HAS_INDICATION": 12,
      "DEVICE_IMPLEMENTS_ASSAY": 11,
      "ASSAY_IMPLEMENTS_DEVICE": 11,
      "DEVICE_HAS_INTENDED_USE": 11,
      "STEP_GENERATES_RESULT": 10,
      "ASSAY_USES_SPECIMEN": 10,
      "DEVICE_HAS_CLASSIFICATION": 9,
      "DEVICE_REFERENCES_DOCUMENT": 8,
      "DEVICE_COMPARED_TO_PREDICATE": 8,
      "SOP_FOLLOWS_GUIDELINE": 7,
      "SOP_DESCRIBES_ASSAY": 7,
      "ASSAY_DETECTS_ANALYTE": 7,
      "ASSAY_RUNS_ON_INSTRUMENT": 7,
      "DEVICE_HAS_PRODUCT_CODE": 6,
      "DEVICE_REGULATED_BY_SECTION": 6,
      "DEVICE_ANALYZES_SPECIMEN": 6,
      "DEVICE_RUNS_ON_INSTRUMENT": 6,
      "DEVICE_MANUFACTURED_BY": 3,
      "DEVICE_HAS_PERFORMANCE": 3,
      "DEVICE_FOLLOWS_STANDARD": 3,
      "SPECIMEN_TYPE_MATCH": 2
    },
    "document_sources": {
      "data/parsed/LabDocs/Procedures/11-DESOXYCORTISOL.md": 23,
      "data/parsed/LabDocs/Procedures/11-NOR-DELTA-9-TETRAHYDROCANNABINOL-9-CARBOXYLIC_ACID_CARBOXY-THC_CONFIRMATION_MECONIUM.md": 17,
      "data/parsed/LabDocs/Procedures/11-DEOXYCORTISOL_SERUM.md": 15,
      "data/parsed/LabDocs/Procedures/11-DEOXYCORTICOSTERONE_SERUM.md": 14,
      "data/parsed/LabDocs/FDA/Pathology/K172174.md": 12,
      "data/parsed/LabDocs/FDA/Pathology/FDA_PATHOLOGY_K243871.md": 7,
      "data/parsed/LabDocs/Procedures/11-NOR-DELTA-9-TETRAHYDROCANNABINOL-9-CARBOXYLIC_ACID_CARBOXY-THC_CONFIRMATION_CHAIN_OF_CUSTODY_MECONIUM.md": 6,
      "data/parsed/LabDocs/FDA/Pathology/FDA_PATHOLOGY_K192259_REVIEW.md": 6,
      "data/parsed/LabDocs/FDA/Molecular Genetics/K190076.md": 3,
      "data/parsed/LabDocs/FDA/Molecular Genetics/K173492.md": 2
    },
    "sop_count": 6,
    "assay_count": 3
  },
  "queries": [
    {
      "query": "How many documents do we have indexed?",
      "answer": "This information is not available in the current knowledge base.",
      "status": "success"
    },
    {
      "query": "What are the main types of documents?",
      "answer": "**The primary document types referenced in the knowledge base are:**\n\n- **Standard Operating Procedures (SOPs)** – e.g., *Standard Operating Procedure for Analytical Phase of 11‑Deoxycortisol, Serum* (defines pre‑analysis, analysis, and post‑analysis steps).  \n- **Analytical Protocols** – e.g., *Protocol for Analytical Phase of Generating Results for 11‑Deoxycortisol* (describes specimen preparation, extraction, LC‑MS/MS analysis, and quantification).  \n- **Manufacturer Instructions** – cited by the SOP for 11‑Deoxycortisol as a required reference document.  \n- **Reference PDF Documents** – e.g., *11‑DESOXYCORTISOL.pdf* (referenced by the analytical protocol).  \n\n*These categories constitute the main types of documents governing the analytical workflow for 11‑Deoxycortisol in the provided context.*",
      "status": "success"
    },
    {
      "query": "What procedures are available in the knowledge base?",
      "answer": "- Standard Operating Procedure for Analytical Phase of 11‑Deoxycortisol, Serum  \n- Protocol for Analytical Phase of Generating Results for 11‑Deoxycortisol  \n- Standard Operating Procedure – Carboxy‑THC Confirmation in Meconium  \n- Standard Operating Procedure: Analytical Phase for Carboxy‑THC Confirmation in Meconium  \n- 510(k) Determination – MolecularMD MRDx BCR‑ABL Test  \n- 510(k) Determination – Xpert BCR‑ABL Ultra, GeneXpert Dx System, GeneXpert Infinity‑48s and GeneXpert Infinity‑80 Systems",
      "status": "success"
    },
    {
      "query": "What instruments are used in the laboratory?",
      "answer": "The laboratory utilizes the following instruments as documented in the knowledge base:\n\n- **LC‑MS/MS system** – employed during the **LC‑MS/MS Analysis** step of the *Protocol for Analytical Phase of Generating Results for 11‑Deoxycortisol* (procedure step “LC‑MS/MS Analysis”).  \n- **GeneXpert Dx System**, **GeneXpert Infinity‑48s**, and **GeneXpert Infinity‑80 Systems** – referenced in the *510(k) Determination – Xpert BCR‑ABL Ultra, GeneXpert Dx System, GeneXpert Infinity‑48s and GeneXpert Infinity‑80 Systems* document.  \n- **MolecularMD MRDx** device – described in the *510(k) Determination – MolecularMD MRDx BCR‑ABL Test* document.  \n\nThese instruments are explicitly mentioned in the SOP‑related documents and are the only equipment identified in the provided knowledge graph.",
      "status": "success"
    },
    {
      "query": "What analytes can be measured?",
      "answer": "The analytical procedure is designed to measure **11‑Deoxycortisol in serum**【Standard Operating Procedure for Analytical Phase of 11-Deoxycortisol, Serum】.  \n\n*Note: The SOP’s documented limitations pertain to specimen collection (use of anticoagulant‑containing tubes) and labeling, but do not affect the identity of the analyte measured.*",
      "status": "success"
    },
    {
      "query": "What specimen types are used?",
      "answer": "The analytical procedures described employ **serum specimens** (i.e., blood collected in tubes **without anticoagulants**).  \n\n- The *Standard Operating Procedure for Analytical Phase of 11‑Deoxycortisol, Serum* specifies that specimens collected in tubes containing anticoagulants are a limitation, indicating that the intended specimen type is serum.  \n- It also notes that specimens showing evidence of hemolysis or lipemia are unacceptable, reinforcing the requirement for clean serum samples.  \n\n*Source: Standard Operating Procedure for Analytical Phase of 11‑Deoxycortisol, Serum.*",
      "status": "success"
    },
    {
      "query": "How many SOPs are in the database?",
      "answer": "There are **three** Standard Operating Procedures (SOPs) represented in the knowledge base:\n\n- **Standard Operating Procedure for Analytical Phase of 11‑Deoxycortisol, Serum**\n- **Standard Operating Procedure – Carboxy‑THC Confirmation in Meconium**\n- **Standard Operating Procedure: Analytical Phase for Carboxy‑THC Confirmation in Meconium**",
      "status": "success"
    },
    {
      "query": "What are the most common relationship types?",
      "answer": "**Most common relationship types in the provided Knowledge Graph**\n\n- **SOP_HAS_PROCEDURE_STEP** – appears 6 times (e.g., linking the “Standard Operating Procedure for Analytical Phase of 11‑Deoxycortisol, Serum” to Pre‑Analysis, Analysis, Post‑Analysis, and linking the “Protocol for Analytical Phase of Generating Results for 11‑Deoxycortisol” to Preparation of Specimen, Extraction of 11‑Deoxycortisol, LC‑MS/MS Analysis).  \n- **STEP_REQUIRES_EQUIPMENT** – appears 3 times (Chromatographic Analysis → HPLC or LC‑MS/MS; Pre‑Analysis → Spectrophotometer; Analysis → Spectrophotometer).  \n- **SOP_HAS_LIMITATION** – appears 3 times (limitations regarding anticoagulant tubes, improper labeling, hemolysis/lipemia).  \n- **STEP_USES_REAGENT** – appears 3 times (Pre‑Analysis, Analysis, Post‑Analysis each use the 11‑Deoxycortisol assay reagent).  \n\nThese relationship types are the most frequently represented in the current knowledge base.",
      "status": "success"
    },
    {
      "query": "What equipment is needed for laboratory procedures?",
      "answer": "**Equipment required for the laboratory procedures described in the knowledge base:**\n\n- **Spectrophotometer** – required during both the Pre‑Analysis and Analysis steps of the *Standard Operating Procedure for Analytical Phase of 11‑Deoxycortisol, Serum*【Pre‑Analysis -[STEP_REQUIRES_EQUIPMENT]-> Spectrophotometer】【Analysis -[STEP_REQUIRES_EQUIPMENT]-> Spectrophotometer】.  \n- **LC‑MS/MS system** – employed in the *LC‑MS/MS Analysis* step of the *Protocol for Analytical Phase of Generating Results for 11‑Deoxycortisol*【Protocol for Analytical Phase of Generating Results for 11‑Deoxycortisol -[SOP_HAS_PROCEDURE_STEP]-> LC‑MS/MS Analysis】.  \n\n*Note:* The knowledge graph does not list any additional equipment beyond the spectrophotometer and the LC‑MS/MS system for the specified procedures.",
      "status": "success"
    },
    {
      "query": "What methods are used for analysis?",
      "answer": "The analysis step employs **liquid chromatography‑tandem mass spectrometry (LC‑MS/MS)** as the primary method for detecting and quantifying 11‑deoxycortisol.\n\n- The **Protocol for Analytical Phase of Generating Results for 11‑Deoxycortisol** lists “LC‑MS/MS Analysis” as a distinct procedure step【Protocol for Analytical Phase of Generating Results for 11‑Deoxycortisol -[SOP_HAS_PROCEDURE_STEP]-> LC‑MS/MS Analysis】.  \n- This LC‑MS/MS step is part of the overall **11‑Deoxycortisol Assay** described in the same protocol【Protocol for Analytical Phase of Generating Results for 11‑Deoxycortisol -[SOP_DESCRIBES_ASSAY]-> 11‑Deoxycortisol Assay】.  \n\nThus, the method used for analysis in the SOPs is LC‑MS/MS.",
      "status": "success"
    }
  ]
}